Skye Bioscience, Inc.
SKYE · Pharmaceutical Preparations
Latest available SEC filing: 4 ·
Latest disclosures
-
Schwab Andrew J.: Form 4
Insider disclosure · Filed · Report period 22 Sep 2026
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Latest financial period: Q2 2026
Financial facts · Filed
Institutional holders by security
Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.
Company details and SEC sources
CIK 0001516551 · SEC filing index. Filing dates describe disclosures, not live market data.
- Listed symbols
- SKYE on Nasdaq
- SEC industry group
- Pharmaceutical Preparations (Office of Life Sciences)
- Business address
- 11250 El Camino Real, Suite 100, San Diego, CA, 92130
- Incorporated in
- NV
- Fiscal year end
- 31 December
- Former names on EDGAR
-
Emerald Bioscience Inc. (to 07 Jan 2021) Nemus Bioscience Inc. (to 14 Mar 2019) LOAD GUARD LOGISTICS INC. (to 30 Oct 2014) LOAD GUARD TRANSPORTATION INC. (to 07 Nov 2012)
At a glance
Names, identifiers, and filing context for this profile.
2 identity fields